BioNTech SE's RNA-based vaccine for malaria placed on clinical hold by FDA
BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the ...
U.S. FDA places clinical hold on BioNTech's malaria vaccine study
BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...
Early mRNA vaccine trial results show potential breakthrough in fighting one of the deadliest cancers
Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...
BioNTech reports FDA clinical hold on Phase I/IIa trial of BNT165e
In a regulatory filing, BioNTech (BNTX) disclosed that the U.S. Food and Drug Administration has informed BioNTech SE that it has placed a ...
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
Yale Daily News16h
Yale scientists design personalized cancer vaccine
A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...
FOX News on MSN11d
Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
RFK Jr. pauses Peninsula company's oral Covid vaccine clinical trial
Federal funding for a Bay Area biotech company's potential half-billion-dollar oral Covid-19 vaccine project has been paused ...
Pancreatic Cancer Vaccine Shows Potential in Early Trial
The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...
CBS News on MSN13d
Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Breast cancer vaccine results promising, moves to next stage in clinical trials
A vaccine to prevent breast cancer is showing good results, and moving into the next stage of clinical trials.
BioNTech stock falls after FDA clinical hold on malaria vaccine trial
The FDA’s clinical hold has prompted a cautious response from investors, reflecting the heightened regulatory scrutiny that BioNTech now faces. The company’s immediate focus will be on resolving the ...